Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional

The purpose of this NOFO is to encourage new approaches to support therapeutic development in ultra-rare pediatric and adult cancers, including molecularly-defined subsets of more common cancers.

credit:

Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Food and Drug Administration

Estimated Funding: $500,000


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
U.S. Mission Japan Federal Assistance Awards

Additional Information of Eligibility:
Foreign Organizations Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.

Non-domestic (non-U.S.) components of U. S. Organizations are eligible to apply.

Foreign components, as defined in the HHS Grants Policy Statement are allowed.

Full Opportunity Web Address:
https://jp.usembassy.gov/federal-assistance-awards/

Contact:


Agency Email Description:
Work

Agency Email:


Date Posted:
2024-01-31

Application Due Date:


Archive Date:
2024-05-05


Chief executive of HCT, Dai Powell, shares the experiences and practical lessons he learned along the way when teaming up with Ealing Community Transport to deliver site transport during the Olympic Park construction.






More Federal Domestic Assistance Programs


Hydrogen Storage Research and Development | Disadvantaged Business Enterprises_Short Term Lending Program | Internship Program for Postsecondary Students | Early Doctoral Student Research Grants | Childhood Lead Poisoning Prevention Projects_State and Local Childhood Lead Poisoning Prevention and |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders